Roles of p38 MAPKs in invasion and metastasis.

Cells from primary tumours need to go through several steps to become fully metastatic. During this process, cancer cells acquire the ability to invade, migrate across the surrounding tissue, enter into the circulation and colonize distant organs. In the present paper, we review recent progress in understanding how the p38 MAPK (mitogen-activated protein kinase) signalling pathway participates in the different steps of metastasis. Experimental evidence suggests that tumour cells need to modulate p38 MAPK activity levels to successfully metastasize.

[1]  H. Höfler,et al.  Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients , 2010, Virchows Archiv.

[2]  P. Bragado,et al.  Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence. , 2009, Cancer research.

[3]  J. Pollard,et al.  Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.

[4]  C. Heldin,et al.  The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner , 2008, Nature Cell Biology.

[5]  J. Huot,et al.  Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases , 2006, Oncogene.

[6]  G. Nemerow,et al.  Urokinase Plasminogen Activator/Urokinase-specific Surface Receptor Expression and Matrix Invasion by Breast Cancer Cells Requires Constitutive p38α Mitogen-activated Protein Kinase Activity* , 2000, The Journal of Biological Chemistry.

[7]  Sang-Gu Hwang,et al.  Phospholipase A2 Activity of Peroxiredoxin 6 Promotes Invasion and Metastasis of Lung Cancer Cells , 2010, Molecular Cancer Therapeutics.

[8]  J. Erler,et al.  Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. , 2009, Cancer cell.

[9]  M. Nishita,et al.  MAPKAPK‐2‐mediated LIM‐kinase activation is critical for VEGF‐induced actin remodeling and cell migration , 2006, The EMBO journal.

[10]  A. Lin,et al.  Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7. , 2005, Cancer research.

[11]  P. Gierschik,et al.  Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38. , 2006, Cellular signalling.

[12]  Y. Hsieh,et al.  Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway. , 2010, European journal of cell biology.

[13]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[14]  Gabriella De Vita,et al.  p38α MAP Kinase as a Sensor of Reactive Oxygen Species in Tumorigenesis , 2007 .

[15]  D. Huo,et al.  The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma. , 2006, Cancer research.

[16]  Q. Hamid,et al.  IL-17 Promotes p38 MAPK-Dependent Endothelial Activation Enhancing Neutrophil Recruitment to Sites of Inflammation , 2010, The Journal of Immunology.

[17]  A. Cuadrado,et al.  p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. , 2007, Cancer cell.

[18]  Yi-Hsien Hsieh,et al.  p38 mitogen-activated protein kinase pathway is involved in protein kinase Calpha-regulated invasion in human hepatocellular carcinoma cells. , 2007, Cancer research.

[19]  Hiroyuki Aburatani,et al.  Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis , 2006, Nature Cell Biology.

[20]  T. Iftner,et al.  p38γ MAPK Cooperates with c-Jun in trans-Activating Matrix Metalloproteinase 9* , 2010, The Journal of Biological Chemistry.

[21]  J. S. Gutkind,et al.  Snail up-regulates proinflammatory mediators and inhibits differentiation in oral keratinocytes. , 2008, Cancer research.

[22]  D. Albertson,et al.  Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability , 2005, Nature.

[23]  K. Valerie,et al.  Transendothelial Migration of Colon Carcinoma Cells Requires Expression of E-selectin by Endothelial Cells and Activation of Stress-activated Protein Kinase-2 (SAPK2/p38) in the Tumor Cells* , 2001, The Journal of Biological Chemistry.

[24]  S. Merajver,et al.  Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis , 2010, Molecular Cancer.

[25]  Jenny G. Parvani,et al.  Noncanonical TGF-β Signaling During Mammary Tumorigenesis , 2011, Journal of Mammary Gland Biology and Neoplasia.

[26]  G. Mills,et al.  Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression , 2011, Oncogene.

[27]  Jun Qin,et al.  Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasiveness. , 2011, Cancer research.

[28]  O. Rath,et al.  Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3β. , 2011, Cancer research.

[29]  R. Bergan,et al.  MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer , 2006, Oncogene.

[30]  D. Kirschmann,et al.  Lysyl oxidase contributes to mechanotransduction-mediated regulation of transforming growth factor-β signaling in breast cancer cells. , 2011, Neoplasia.

[31]  J. Huot,et al.  Integrating the VEGF signals leading to actin-based motility in vascular endothelial cells. , 2000, Trends in cardiovascular medicine.

[32]  J. Westermarck,et al.  p38α and p38δ mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells , 2007, Oncogene.

[33]  R. Jain,et al.  C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells , 2010, Proceedings of the National Academy of Sciences.

[34]  Julio A. Aguirre.  Models, mechanisms and clinical evidence for cancer dormancy , 2007 .

[35]  M. Yamashita,et al.  TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. , 2008, Molecular cell.

[36]  K. Anderson,et al.  p38 and a p38-Interacting Protein Are Critical for Downregulation of E-Cadherin during Mouse Gastrulation , 2006, Cell.

[37]  P. Cohen,et al.  CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPK-MAPKAP-K2-HSP27 pathway. , 2006, Cellular signalling.

[38]  M. Nieto,et al.  Inflammation and EMT: an alliance towards organ fibrosis and cancer progression , 2009, EMBO molecular medicine.

[39]  L. Platanias,et al.  Mitochondrial Reactive Oxygen Species Activation of p38 Mitogen-Activated Protein Kinase Is Required for Hypoxia Signaling , 2005, Molecular and Cellular Biology.

[40]  Baolin Zhang,et al.  Silencing of D4-GDI Inhibits Growth and Invasive Behavior in MDA-MB-231 Cells by Activation of Rac-dependent p38 and JNK Signaling , 2009, Journal of Biological Chemistry.

[41]  M. Bar‐eli,et al.  Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype , 2010, Proceedings of the National Academy of Sciences.

[42]  A. Fornace,et al.  p38 MAP kinase's emerging role as a tumor suppressor. , 2004, Advances in cancer research.

[43]  Xiaoyi Mi,et al.  Integrin β3 and its ligand regulate the expression of uPA through p38 MAPK in breast cancer , 2010, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[44]  J. Boehm,et al.  p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases , 2003, Nature Reviews Drug Discovery.

[45]  R. Toillon,et al.  TrkA overexpression enhances growth and metastasis of breast cancer cells , 2009, Oncogene.

[46]  P. Vincent,et al.  Activation of p38 Has Opposing Effects on the Proliferation and Migration of Endothelial Cells* , 2005, Journal of Biological Chemistry.

[47]  J. Aguirre-Ghiso,et al.  Models, mechanisms and clinical evidence for cancer dormancy , 2007, Nature Reviews Cancer.

[48]  E. Wagner,et al.  Signal integration by JNK and p38 MAPK pathways in cancer development , 2009, Nature Reviews Cancer.

[49]  C. López-Otín,et al.  Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. , 2000, Journal of cell science.

[50]  Á. Avivar-Valderas,et al.  p38α Signaling Induces Anoikis and Lumen Formation During Mammary Morphogenesis , 2011, Science Signaling.

[51]  A. Cuadrado,et al.  Mechanisms and functions of p38 MAPK signalling. , 2010, The Biochemical journal.

[52]  L. Zhang,et al.  Apoptosis commitment and activation of mitochondrial Bax during anoikis is regulated by p38MAPK , 2009, Cell Death and Differentiation.

[53]  F. Vesuna,et al.  Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells , 2009, Oncogene.

[54]  C. Beaudry,et al.  MAP-ing glioma invasion: Mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival , 2007, Molecular Cancer Therapeutics.

[55]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[56]  B. Kreike,et al.  p38γ mitogen-activated protein kinase contributes to oncogenic properties maintenance and resistance to poly (ADP-ribose)-polymerase-1 inhibition in breast cancer. , 2011, Neoplasia.

[57]  M. Foronda,et al.  p38 maintains E-cadherin expression by modulating TAK1–NF-κB during epithelial-to-mesenchymal transition , 2010, Journal of Cell Science.

[58]  Paula D. Bos,et al.  Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.

[59]  T. Kuriyama,et al.  Involvement of p38α Mitogen-activated Protein Kinase in Lung Metastasis of Tumor Cells* , 2006, Journal of Biological Chemistry.

[60]  A. Zauberman,et al.  Stress activated protein kinase p38 is involved in IL-6 induced transcriptional activation of STAT3 , 1999, Oncogene.

[61]  A. Abdollahi,et al.  Phenotype-assisted transcriptome analysis identifies FOXM1 downstream from Ras–MKK3–p38 to regulate in vitro cellular invasion , 2010, Oncogene.

[62]  P. Carmeliet,et al.  uPAR: a versatile signalling orchestrator , 2002, Nature Reviews Molecular Cell Biology.